$AGX · Schwab Network · 2026-11-10
AGX 是说话者的选股。他将其描述为一家生命科学企业,生产用于化学、药物以及市政水/污染物研究的色谱/光谱仪;其近乎寡头的地位支撑着巨大的增长路径,并在未来具备不错的定价能力。
播放时,YouTube 可能接收设备与播放信息并使用 Cookie。 隐私说明 · Google 隐私政策
逐段跳播
我们也来谈谈 Agyant,这实际上是你今天选出的股票。是的。你看,这是一家生命科学公司。他们制造色谱和光谱仪器。基本上就是制造帮助研究化学物质、帮助研究药物科学的机器。甚至政府、地方市政部门在做市政供水、污染物之类的研究时也喜欢用这类设备。
所以他们制造的就是这类机器,而且这实际上是一个寡头垄断的行业。因此他们有一条巨大的增长路径,未来也有相当不错的定价权。
Let's also talk about Agyant that is actually your stock pick today. Yeah. So look, life sciences company. They make chromatography spectrometry machines. That's just basically they they they build they build machines that help study chemicals that help study uh you know drug science.
Um and you know even government you know local municipalities like to to do studies when it comes to things like municipal wa water and pollutants and things of that nature. And so that's those are the types of machines um that they build and it's really an igopoly.
So they have a you know a tremendous path for growth and pretty decent pricing power going forward.